News - Patents

Filter

Current filters:

Patents

Popular Filters

140 to 164 of 432 results

Activists protest in front of the European Parliament to stop EU-India trade deal "harmful" provisions

09-04-2013

As European Commission pressure mounts on India to rush into signing a free trade agreement (FTA) by…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPoliticsPricing

Both biosimilar and reference biologics companies must consider product-specific and regional strategies

09-04-2013

With sales forecasted to exceed $16.8 billion by 2021, manufacturers competing in the biosimilars market…

BiotechnologyGenericsMarkets & MarketingPatentsProductionResearch

Vision for "better health through research" in Australia set out in new report

05-04-2013

Australian Minister for Health Tanya Plibersek on April 5 released the report of the McKeon Review -…

Asia-PacificBiotechnologyFinancialPatentsPharmaceuticalResearch

Cyclacel sells four disputed romidepsin-related patents to Celgene

05-04-2013

USA based Cyclacel Pharmaceuticals (Nasdaq: CYCC) says that it has entered into a definitive agreement…

BiotechnologyCelgeneCyclacel PharmaceuticalsLegalOncologyPatentsromidepsin

US-India Business Council has concerns over India's ruling on Novartis' Glivec

03-04-2013

This week's long awaited Supreme Court of India ruling, which denied a patent on Swiss drug major Novartis'…

Asia-PacificGenericsGlivecNovartisPatentsPharmaceutical

India's Supreme Court denies Novartis Glivec patent appeal

02-04-2013

In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

Analysis of China government incentives for pharma

27-03-2013

China remains an attractive target for pharmaceutical research and manufacturing, and major players from…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPatentsPharmaceutical

Daiichi Sankyo sets out five-year plan to overcome Olmetec patent expiry

25-03-2013

Japanese drug major Daiichi Sankyo (TYO: 4568) has announced a new five-year Business Plan, which will…

Daiichi SankyoFinancialolmesartanOlmetecPatentsPharmaceuticalRanbaxy Laboratories

AstraZeneca in Crestor patent settlement with Actavis and EGIS Pharma

25-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a settlement agreement in its US patent…

ActavisCardio-vascularCrestorGenericsNorth AmericaPatentsPharmaceuticalrosuvastatinShionogiWatson Pharmaceuticals

US lobby group pressures Greek government to introduce compulsory licensing of drugs

19-03-2013

USA-based not-for-profit lobby group Essential Inventions has written to Greek Health Minister Andreas…

EuropeGenericsHealthcarePatentsPharmaceuticalPricing

Business faces "fundamental change" in protecting inventions in the USA

15-03-2013

From Saturday, March 16, organizations looking to protect their inventions in the USA will face significantly…

BiotechnologyNorth AmericaPatentsPharmaceutical

DNP+ and MSF urge India to reject EU demands on trade deal before April deadline

13-03-2013

Pressure is mounting on India to quickly sign off on a free trade agreement with the European Union which…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPolitics

European Patent Office maintains Pozen's PA/Vimovo patent

12-03-2013

US drug firm Pozen (Nasdaq: POZN) says that the Opposition Division of the European Patent Office has…

AstraZenecaEuropeInflammatory diseasesPatentsPharmaceuticalPozenVimovo

Thailand flouts pharmaceutical patent protection; report

08-03-2013

Lax enforcement of patent regulations in Thailand is alienating American intellectual property laws,…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceutical

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

Call for strong Trans-Pacific intellectual property framework from PhRMA

05-03-2013

The Pharmaceutical Research and Manufacturers of America (PhRMA) this week called on nations participating…

Asia-PacificBiotechnologyNorth AmericaPatentsPharmaceuticalSouth America

140 to 164 of 432 results

Company Spotlight

Fibrotech

Fibrotech

Back to top